Welcome to yet another edition of PharmIndia Newsletter for all Pharmainfo.net users.Now that you all are familiar with my newsletters I try to bring before you some of the events, news & topics happening in Pharma Industry. I have always loved to get you response & support this activity so wait no more go through this week’s edition & as soon as you finish write your comment to enhance further the PharmIndia newsletter.

I would like to wish each & every friend here on Pharmainfo.net & the Pharmainfo.net team a very Happy Frienship Day.

Friendship day… Again another day to remember all those friends who have been a part of your life… Again not that you need a day to acknowledge their importance in your life.

Dear Friends here is yet another newsletter giving you recent news & happenings in our field.

Statins May Protect Against Memory Loss

People at high risk for dementia who took cholesterol-lowering statins are half as likely to develop dementia as those who do not take statins, a new study shows. Details

Research indicates Tea may improve attention and focus

Dear friends, continued from my last two posts I am again giving here some more technical terms 

Dear friends, continued from last post I am again giving here some more technical terms.

Dear friends, I am writing some blogs which will describe the technical terms which many a time are very much needed to be understood. These are helpful and there are many terms of which I am trying to give some important terms.  Some of these may be new while some may be which you are familiar with. Please do give your comments & suggestions on this effort.

Technical Jargon: Terms used, which you should know

Fragment-based drug design (FBDD) has emerged as an alternative approach to traditional lead identification and is increasingly being used in large pharmaceutical settings to improve the drug discovery cycle. The results from these projects highlight the strength and shortcomings of FBDD in assisting drug discovery.

Image source: http://www.unil.ch/webdav/site/pmf/shared/Technologies/DD-1.jpg

Recent years have seen a tremendous increase in the technologies available for the discovery of new drugs. Functional genomics research has led to the identification of an unprecedented number of potential therapeutic protein targets; combinatorial chemistry has expanded the size of compound collections; and high-throughput screening (HTS) has enabled the screening of million-compound libraries.